RxTROSPECT ANALYTICS
Learn about our flagship offering that reveals all approvals across Europe and United States in oncology
Navigate every drug approved by the FDA, drill-down into specific approval details and find a precedent to support your regulatory strategy or optimal approval pathway
Explore all drugs approved by the EMA, including rapid access to rapporteur and co-rapporteur evaluations. Get immediate insight into approvals over past decades
RxTROSPECT DISCOVERY
Learn about our marquee offering that ingests our dataset into your company’s centralized knowledge platform. Tailored to those consolidating diverse datasets
Discover the benefits of our uniquely curated dataset that has become the primary choice for digital regulatory strategists and intelligence teams